Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

The PTPN22 locus is one of the strongest risk factors outside of the major histocompatability complex that associates with autoimmune diseases. PTPN22 encodes lymphoid protein tyrosine phosphatase (Lyp) which is expressed exclusively in immune cells. A single base change in the coding region of this gene resulting in an arginine to tryptophan amino acid substitution within a polyproline binding motif associates with type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosis, Hashimotos thyroiditis, Graves disease, Addison's disease, Myasthenia Gravis, vitiligo, systemic sclerosis juvenile idiopathic arthritis and psoriatic arthritis. Here, we review the current understanding of the PTPN22 locus from a genetic, geographical, biochemical and functional perspective.

[1]  I. I. Smirnov,et al.  The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. , 2006, Tissue antigens.

[2]  N. Bottini,et al.  Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain. , 2009, Biochemistry.

[3]  K. Amrein,et al.  Csk-mediated phosphorylation of substrates is regulated by substrate tyrosine phosphorylation. , 1998, Farmaco.

[4]  J. Cloutier,et al.  Sequence Requirements for Association of Protein-tyrosine Phosphatase PEP with the Src Homology 3 Domain of Inhibitory Tyrosine Protein Kinase p50 csk * , 1998, The Journal of Biological Chemistry.

[5]  Wendy Thomson,et al.  Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.

[6]  T. Hamaoka,et al.  Localization of PTP-FERM in nerve processes through its FERM domain. , 2002, Biochemical and biophysical research communications.

[7]  T. Habib,et al.  Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling1 , 2009, The Journal of Immunology.

[8]  T. Pawson,et al.  Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.

[9]  F. Tsui,et al.  Molecular Basis of the Motheaten Phenotype , 1994, Immunological reviews.

[10]  R. Płoski,et al.  Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves’ disease in a Polish population: association and gene dose‐dependent correlation with age of onset , 2005, Clinical endocrinology.

[11]  M. Tremblay,et al.  Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model. , 1998, Biochemistry.

[12]  Nunzio Bottini,et al.  Protein tyrosine phosphatases and the immune response , 2005, Nature Reviews Immunology.

[13]  Jill Cheng,et al.  PSTPIP: A Tyrosine Phosphorylated Cleavage Furrow–associated Protein that Is a Substrate for a PEST Tyrosine Phosphatase , 1997, The Journal of cell biology.

[14]  Steven J. Schrodi,et al.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. , 2004, American journal of human genetics.

[15]  K. Boberg,et al.  Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases , 2005, Genes and Immunity.

[16]  Steven R. Williams,et al.  Identification of Substrates of Human Protein-tyrosine Phosphatase PTPN22* , 2006, Journal of Biological Chemistry.

[17]  R. Quinton,et al.  The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  M. Thomas,et al.  Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences , 1992, Molecular and cellular biology.

[19]  T. Onytiganis.  Development of ''substrate-trapping'' mutants to identify physiological substrates of protein tyrosine phosphatases , 1997 .

[20]  K. Badenhoop,et al.  Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. , 2005, European journal of endocrinology.

[21]  S. Pierce,et al.  The tipping points in the initiation of B cell signalling: how small changes make big differences , 2010, Nature Reviews Immunology.

[22]  J. Anaya,et al.  PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases , 2005, Genes and Immunity.

[23]  J. Ilonen,et al.  Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. , 2008, Journal of autoimmunity.

[24]  N. Tonks,et al.  Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST , 1996, Molecular and cellular biology.

[25]  F. Vannberg,et al.  PTPN22 and invasive bacterial disease , 2006, Nature Genetics.

[26]  K. Douroudis,et al.  PTPN22 gene regulates natural killer cell proliferation during in vitro expansion. , 2010, Tissue antigens.

[27]  Kenneth G. C. Smith,et al.  Genetic susceptibility to systemic lupus erythematosus protects against cerebral malaria in mice , 2010, Proceedings of the National Academy of Sciences.

[28]  Javier Martín,et al.  Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[29]  A. Alonso,et al.  Protein tyrosine phosphatases in T cell physiology. , 2004, Molecular immunology.

[30]  J A Lopez-Escamez.  A variant of PTPN22 gene conferring risk to autoimmune diseases may protect against tuberculosis. , 2010, Journal of postgraduate medicine.

[31]  P. Jagodziński,et al.  Contribution of the R620W polymorphism of protein tyrosine phosphatase non-receptor 22 to systemic lupus erythematosus in Poland. , 2008, Clinical and experimental rheumatology.

[32]  Omer Dushek,et al.  Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal Transduction , 2010, Immunity.

[33]  Haixia Li,et al.  A PTPN22 promoter polymorphism −1123G>C is associated with RA pathogenesis in Chinese , 2012, Rheumatology International.

[34]  Adrian Vella,et al.  Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. , 2004, Diabetes.

[35]  K. Takase,et al.  [T cell activation]. , 1995, Ryumachi. [Rheumatism].

[36]  Elizabeth W Karlson,et al.  Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. , 2005, American journal of human genetics.

[37]  T. Egeland,et al.  Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease , 2008, European Journal of Human Genetics.

[38]  J. Cloutier,et al.  Cooperative Inhibition of  T-Cell Antigen Receptor Signaling by a Complex between a Kinase and a Phosphatase , 1999, The Journal of experimental medicine.

[39]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[40]  A. Alonso,et al.  Subcellular localization of intracellular protein tyrosine phosphatases in T cells , 2000, European journal of immunology.

[41]  Arthur Weiss,et al.  Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. , 2007, Immunity.

[42]  Tomas Mustelin,et al.  Positive and negative regulation of T-cell activation through kinases and phosphatases. , 2003, The Biochemical journal.

[43]  J. Partanen,et al.  The human p50csk tyrosine kinase phosphorylates p56lck at Tyr‐505 and down regulates its catalytic activity. , 1992, The EMBO journal.

[44]  J. Tuomilehto,et al.  Finnish case–control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis , 2005, Genes and Immunity.

[45]  J. Cloutier,et al.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. , 1996, The EMBO journal.

[46]  R. Majeti,et al.  An Inactivating Point Mutation in the Inhibitory Wedge of CD45 Causes Lymphoproliferation and Autoimmunity , 2000, Cell.

[47]  M. Hermiston,et al.  PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background1 , 2009, The Journal of Immunology.

[48]  J. Jais,et al.  Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis , 2006, Annals of neurology.

[49]  A. Begovich,et al.  Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. , 2005, Arthritis and rheumatism.

[50]  J. Heward,et al.  HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity? , 2005, Expert Reviews in Molecular Medicine.

[51]  Andy Hudmon,et al.  Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases , 2007, Proceedings of the National Academy of Sciences.

[52]  E. Shaoul,et al.  Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. , 1999, Blood.

[53]  L. Diehl,et al.  PEST Domain-Enriched Tyrosine Phosphatase (PEP) Regulation of Effector/Memory T Cells , 2004, Science.

[54]  C. W. Kilpatrick,et al.  Tempo and Mode in the Endocannaboinoid System , 2007, Journal of Molecular Evolution.

[55]  P. Gregersen,et al.  PTPN22: setting thresholds for autoimmunity. , 2006, Seminars in immunology.

[56]  M. Gishizky,et al.  The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. , 2002, Experimental hematology.

[57]  G. Schütz,et al.  Genetically Encoded Förster Resonance Energy Transfer Sensors for the Conformation of the Src Family Kinase Lck1 , 2009, The Journal of Immunology.

[58]  Taylor J. Maxwell,et al.  Deep resequencing reveals excess rare recent variants consistent with explosive population growth , 2010, Nature communications.

[59]  T. Mustelin,et al.  A Weak Lck Tail Bite Is Necessary for Lck Function in T Cell Antigen Receptor Signaling* , 2007, Journal of Biological Chemistry.

[60]  P. Concannon,et al.  Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes1 , 2007, The Journal of Immunology.

[61]  F. Shi,et al.  Natural killer cells in human autoimmunity. , 2009, Current opinion in immunology.

[62]  R. Aebersold,et al.  Activating and Inhibitory Mutations in Adjacent Tyrosines in the Kinase Domain of ZAP-70 (*) , 1995, The Journal of Biological Chemistry.

[63]  T. Merriman,et al.  Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort. , 2005, Arthritis and rheumatism.

[64]  Nunzio Bottini,et al.  Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant , 2005, Nature Genetics.

[65]  O. Cinek,et al.  No independent role of the -1123 G>C and+2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. , 2007, Diabetes research and clinical practice.

[66]  M. González-Escribano,et al.  PTPN22 C1858T polymorphism and the outcome of hepatitis C virus infection. , 2008, Viral immunology.

[67]  P. Woodman.  p97, a protein coping with multiple identities , 2003, Journal of Cell Science.

[68]  Y. Arimura,et al.  Comprehensive Expression Profiles of Genes for Protein Tyrosine Phosphatases in Immune Cells , 2010, Science Signaling.

[69]  V. Tillmann,et al.  Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population. , 2008, Tissue antigens.

[70]  Nunzio Bottini,et al.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes , 2004, Nature Genetics.

[71]  Nunzio Bottini,et al.  Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue* , 2010, The Journal of Biological Chemistry.

[72]  Kristin G Ardlie,et al.  Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. , 2004, American journal of human genetics.

[73]  J. Kuriyan,et al.  The Tyrosine Kinase Csk Dimerizes through Its SH3 Domain , 2009, PloS one.

[74]  C. Morillo,et al.  Association study of PTPN22 C1858T polymorphism in Trypanosoma cruzi infection. , 2007, Tissue antigens.

[75]  L. Cantley,et al.  The Cbl Phosphotyrosine-binding Domain Selects a D(N/D)XpY Motif and Binds to the Tyr292Negative Regulatory Phosphorylation Site of ZAP-70* , 1997, The Journal of Biological Chemistry.

[76]  K. Eguchi,et al.  Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): Association between a promoter polymorphism and type 1 diabetes in Asian populations , 2006 .

[77]  N. Bottini,et al.  Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation . , 2009, Biochemistry.

[78]  Jane Worthington,et al.  Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis , 2010, Annals of the rheumatic diseases.

[79]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[80]  Peter K Gregersen,et al.  Recent advances in the genetics of autoimmune disease. , 2009, Annual review of immunology.

[81]  X. Mariette,et al.  No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome , 2005, Genes and Immunity.

[82]  T. Mustelin,et al.  Association of Protein-tyrosine Phosphatase MEG2 via Its Sec14p Homology Domain with Vesicle-trafficking Proteins* , 2007, Journal of Biological Chemistry.

[83]  M. Dwivedi,et al.  Association of PTPN22 1858C/T polymorphism with vitiligo susceptibility in Gujarat population. , 2008, Journal of dermatological science.

[84]  M. Madaio,et al.  Pathogenic autoantibodies in lupus nephritis , 2005, Lupus.

[85]  N. Bottini,et al.  A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. , 2008, Human molecular genetics.

[86]  A. Zhernakova,et al.  Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population , 2005, Genes and Immunity.

[87]  Yaofeng Zhao,et al.  PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis , 2008, Journal of Neuroimmunology.

[88]  M. Feldmann,et al.  Molecular therapeutic targets in rheumatoid arthritis , 2005, Expert Reviews in Molecular Medicine.

[89]  Annette Lee,et al.  Analysis of Families in the Multiple Autoimmune Disease Genetics Consortium (madgc) Collection: the Ptpn22 620w Allele Associates with Multiple Autoimmune Phenotypes , 2022 .

[90]  R. Spritz,et al.  The PTPN22‐1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population , 2008, Pigment cell & melanoma research.

[91]  Y.H. Lee,et al.  The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update , 2011, Lupus.

[92]  N. Tonks,et al.  Protein tyrosine phosphatases: from genes, to function, to disease , 2006, Nature Reviews Molecular Cell Biology.

[93]  Javier Martín,et al.  PTPN22 C1858T polymorphism and human brucellosis , 2009, Scandinavian journal of infectious diseases.

[94]  C. Pallen,et al.  Protein Tyrosine Phosphatase α Regulates Fyn Activity and Cbp/PAG Phosphorylation in Thymocyte Lipid Rafts1 , 2005, The Journal of Immunology.

[95]  Tomas Mustelin,et al.  Characterization of TCR‐induced receptor‐proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP , 1999, European journal of immunology.

[96]  D. Gawkrodger,et al.  A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo , 2005, Genes and Immunity.

[97]  W. Ho,et al.  Identification of a variant form of tyrosine phosphatase LYP , 2010, BMC Molecular Biology.

[98]  J. She,et al.  Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. , 2005, Diabetes.

[99]  G. Koretzky,et al.  T cell activation. , 2009, Annual review of immunology.

[100]  Javier Martín,et al.  Genetic influence of PTPN22 R620W polymorphism in tuberculosis. , 2005, Human immunology.

[101]  N. Bottini,et al.  Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population. , 2009, Tissue antigens.